Next Article in Journal / Special Issue
Nonsteroidal Anti-Inflammatory Drug-Induced Gastroduodenal Bleeding: Risk Factors and Prevention Strategies
Previous Article in Journal
Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke
Previous Article in Special Issue
Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks
Article Menu

Export Article

Open AccessReview
Pharmaceuticals 2010, 3(7), 2213-2224;

High-Dose Ibuprofen in Cystic Fibrosis

Division of Respiratory Medicine, Montreal Children’s Hospital, D-380, 2300 Tupper Street, Montreal, Quebec, H3H 1P3, Canada
Research Institute of McGill University Health Centre, Montreal Children’s Hospital, C-1223, 2300 Tupper Street, Montreal, Quebec, H3H 1P3, Canada
Author to whom correspondence should be addressed.
Received: 23 June 2010 / Revised: 6 July 2010 / Accepted: 8 July 2010 / Published: 13 July 2010
(This article belongs to the Special Issue Non-Steroidal Anti-Inflammatory Drugs)
Full-Text   |   PDF [123 KB, uploaded 13 July 2010]


Cystic Fibrosis (CF) is the most common lethal genetic disorder in North America and Europe. Most patients succumb to progressive lung disease characterized by an exaggerated neutrophilic inflammation. In animal models of chronic infection, high-dose ibuprofen was demonstrated to reduce inflammation without hindering bacterial clearance. This led to two clinical trials, which demonstrated a benefit in slowing the progression of lung disease in CF. However, concerns about potential adverse effects have limited the use of high-dose ibuprofen in CF patients. There are a variety of potential mechanisms to account for the observed clinical benefit. A better understanding of these mechanisms could potentially lead to more targeted and better-tolerated anti-inflammatory therapies. View Full-Text
Keywords: ibuprofen; interleukin-8; neutrophils; cystic fibrosis; CFTR ibuprofen; interleukin-8; neutrophils; cystic fibrosis; CFTR
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Lands, L.C.; Dauletbaev, N. High-Dose Ibuprofen in Cystic Fibrosis. Pharmaceuticals 2010, 3, 2213-2224.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top